What are they doing?, page-5

Their cash reserve together with next year tax rebate could possibly support a P2 trial or at least one year operation. The yearly high throughput screening may also find out something suddenly and help them to sell more shares... Many reasons can explain the warrant expiration. Life Bio could run out of cash or find it possible to acquire what they need at lower cost; someone may want to block this transaction by pressing down share price etc. A takeover is better than delisting now. This management team is more ridiculous beyond my imagination. I do hope somebody can take over those IPs and commercialize something ASAP. At least it is good for suffering people.